This fact sheet provides a clear, practical overview of MMS’s biometrics capabilities, covering data management, biostatistics, statistical programming, trial design, and regulatory submissions.

It is designed for clinical operations, biometrics leaders, data science teams, and regulatory stakeholders who need a fast, authoritative reference to evaluate biometrics partners for complex or data-intensive trials.

This resource is most useful when sponsors are facing increasing trial complexity, multiple data sources, accelerated timelines, or heightened regulatory oversight expectations, and require a specialist, data-focused CRO rather than a traditional outsourcing model.

This fact sheet explains how MMS delivers end-to-end biometrics solutions that improve data quality, accelerate timelines, and support regulatory-ready submissions.

Key Takeaways / What You’ll Learn

• Understand MMS’s end-to-end biometrics delivery model, from study design through submission.
• Evaluate how Quality by Design and proactive data monitoring reduce rework, delays, and trial risk.
• See how Datacise® enables near real-time operational and data quality oversight.
• Assess MMS’s ability to manage complex trials and emerging data types without compromising timelines.
• Reference measurable outcomes that demonstrate speed, continuity, and cost impact.

Why MMS Is the Right Biometrics Partner

MMS is a specialist, data-focused CRO built to manage the realities of modern clinical development.

Key differentiators include:

• True end-to-end biometrics solutions with a cohesive thread from protocol design to submission.
• Proactive data intervention, using pattern recognition to identify risks early and protect study power.
• Expert handling of complex trials, including multiple external data sources and novel data types.
• Software-enabled oversight, integrating analytics directly into biometrics workflows.

Software-Enabled Insights with Datacise®

Datacise® is MMS’s proprietary data visualization and analytics platform that supports faster, evidence-based decision-making.

It enables sponsors to:

• Improve operational efficiency by reducing manual tracking.
• Strengthen data integrity through early detection of missing data and query trends.
• Meet ICH E6(R3) sponsor oversight expectations with documented, real-time visibility.

Datacise® provides near real-time insights into clinical trial operations and data quality, enabling proactive oversight and regulatory confidence.

Biometrics Solutions Fact Sheet: End-to-End Data Expertise for Complex Clinical Trials

Download your Fact Sheet today ↓

Biometrics Capabilities at a Glance

Data Management

• Flexible EDC selection (Zelta, Medidata Rave, Medrio).
• Expedited database builds and optimized eCRF design.
• Real-time oversight through Datacise®.
• Standards libraries supporting compliance and efficiency.
• Proven expertise integrating complex and external data sources.

Biostatistics & Statistical Programming

• Phase I–IV, RWE, HTA, and submission support.
• CDISC-compliant SDTM and ADaM datasets.
• Proprietary automation to reduce manual effort and cycle times.
• Regulatory-ready outputs that accelerate decision-making.

Trial Design & Strategic Statistical Consulting

• KerusCloud® study simulation for design optimization.
• Quantitative modeling to evaluate development scenarios.
• Statistical leadership supporting critical program decisions.

Regulatory Submissions & Oversight

• Regulatory-informed ISS/ISE, BIMO, and submission preparation.
• Annotated CRFs, define.xml, and reviewers’ guides.
• DSMB support and rapid responses to FDA, EMA, and PMDA inquiries.

Demonstrated Value

• 96% team retention, supporting continuity and study knowledge.
• Database go-live in as little as 4–6 weeks.
• LPLV to DBL in as fast as 2 weeks.
• Up to $20M saved on a single study through optimized trial design using KerusCloud®.